News
MONTCO Today on MSN9h
GSK Bets Big on ‘Game-Changing’ Liver Disease DrugGSK has announced a $1.2 billion deal to acquire efimosfermin alfa from Boston Pharmaceuticals, writes John George for the ...
Zacks Investment Research on MSN2h
Pharma Stock Roundup: BAYRY Q1 Earnings, NVO & GSK's New DealsBayer BAYRY announced first-quarter 2025 results. Novo Nordisk NVO and GSK plc GSK announced licensing deals with smaller ...
USA-based Inozyme Pharma, a biopharma developing innovative therapeutics for rare diseases that affect bone health and blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback